Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Xponential Fitness, Inc. (XPOF)
NYSEConsumer DiscretionaryLeisureSnapshot 2026-11-04
$4.53-0.44%
Close 2026-11-04 · 1-day change
NYSEConsumer DiscretionaryLeisureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.49 → 0.49 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for XPOF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve cash from operations toward positive territory | Cash flow from operations is improving but still negative. | Broken | Cash from operations remains negative or worsens over next year | Cash from operations: $-4.038M FY2026-Q2; GAAP. Published target: Cash from operations improves from -$21.7M in Q1 2026. Target period is not explicitly aligned with this observation. Aug 7, 2026-4,038,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk, loss-making business with a volatile management record, not yet a demonstrated durable growth story. The thesis is in a watch state: momentum has improved from a weak level, but recent results remain below the industry cohort.
The shares are tagged as stretched and trade at a premium to peers, with low confidence in the valuation model. The expectations gap is modest, while the valuation case partly reflects optionality, meaning possible value from future strategic outcomes; the evidence does not show that those outcomes have been delivered.
Near term, execution remains difficult: Q2 2026 revenue fell 13% year over year, and full-year revenue guidance and planned studio openings were both reduced. Management continues to emphasize revenue growth and studio expansion, but delivery has not matched those aims; elevated earnings-miss risk adds uncertainty to the next quarter.
A favorable scenario depends on a reversal in guidance next quarter and on continued strength from sector bellwethers. If those companies miss or lower guidance, the sector support could fade. The ongoing strategic-alternatives review and recent material agreement are additional possible swing factors, but the evidence gives no reported financial outcome from the review.
Over the next one to three years, the thesis depends on XPOF restoring revenue and expansion progress while turning strategic actions into clear results. Until execution improves, the loss-making profile, elevated risk, and stretched peer valuation leave the multi-year view uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Xponential Fitness, Inc.'s published investment case. The stated target is No further key executive departures in next 12 months. |
| Under Pressure |
| Additional CEO, COO, or President departures occur |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches $260M to $270M in full year 2026 | A primary condition in Xponential Fitness, Inc.'s published investment case. The stated target is >= $260M and <= $270M. | Broken | Full year 2026 revenue falls below $260M | Revenue: $2.703M FY2026-Q2; GAAP. Published target: >= $260M and <= $270M. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 20262,703,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Open 150 to 170 new studios in 2026 | It plans to open 150 to 170 new studios this year. | Intact | Net new studio openings fall below 150 in 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.77 → $0.49 · observed estimates
$0.28B → $0.27B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-07-25 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-07-26 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-07-27 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-07-28 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-07-29 | $0.73 | $279,231,381 | 4 / 6 |
| 2026-07-30 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-07-31 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-08-01 | $0.73 | $279,231,381 | 4 / 6 |
| 2026-08-02 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-08-03 | $0.73 | $279,231,381 | 4 / 6 |
| 2026-08-04 | $0.77 | $279,496,210 | 6 / 8 |
| 2026-08-05 | $0.76 | $280,317,100 | 5 / 7 |
| 2026-08-06 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-08 | $0.75 | $275,859,950 | 4 / 7 |
| 2026-08-09 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-10 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-12 | $0.66 | $271,165,240 | 4 / 7 |
| 2026-08-13 | $0.66 | $271,165,240 | 4 / 7 |
| 2026-08-14 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-15 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-16 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-17 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-18 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-19 | $0.71 | $280,153,278 | 4 / 6 |
| 2026-08-20 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-21 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-22 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-23 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-24 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-25 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-26 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-27 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-28 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-29 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-30 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-08-31 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-01 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-02 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-03 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-04 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-05 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-06 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-07 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-08 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-09 | $0.57 | $271,222,381 | 4 / 6 |
| 2026-09-10 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-11 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-12 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-13 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-14 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-15 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-16 | $0.57 | $271,222,381 | 4 / 5 |
| 2026-09-17 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-18 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-19 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-20 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-21 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-22 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-23 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-24 | $0.49 | $268,852,130 | 4 / 5 |
| 2026-09-25 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-09-26 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-09-27 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-09-28 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-09-29 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-09-30 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-01 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-02 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-03 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-04 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-05 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-06 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-07 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-08 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-09 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-10 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-11 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-12 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-13 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-14 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-15 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-16 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-17 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-18 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-19 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-20 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-21 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-22 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-23 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-24 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-25 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-26 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-27 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-28 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-29 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-30 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-10-31 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-11-01 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-11-02 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-11-03 | $0.49 | $268,852,130 | 3 / 5 |
| 2026-11-04 | $0.49 | $268,852,130 | 3 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.